Lymphatic dysregulation in intestinal inflammation: new insights into inflammatory bowel disease pathomechanisms.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Lymphology

• Publication date

  2014-08-07

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 25109166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

  2014cited by this paper
• Diet and inflammatory bowel disease: review of patient-targeted recommendations.

  2014cited by this paper
• Preliminary Results of the Influence of the In Vivo Use of a Lymphatic Dye (Patent Blue V) in the Surgical Treatment of Crohn’s Disease

  2014cited by this paper
• The endotoxin/toll-like receptor-4 axis mediates gut microvascular dysfunction associated with post-prandial lipidemia

  2013cited by this paper
• Genetic removal of basal nitric oxide enhances contractile activity in isolated murine collecting lymphatic vessels

  2013cited by this paper
• Dietary Patterns and Self-Reported Associations of Diet with Symptoms of Inflammatory Bowel Disease

  2013cited by this paper
• Effects of exogenous vasoactive intestinal peptide on mesenteric lymph pathway during early intestinal ischemia-reperfusion injury in rats.

  2013influential reference
• Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL.

  2013cited by this paper
• Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis.

  2013cited by this paper
• Gut sterilization in experimental colitis leukocyte mediated colon injury, and effects on angiogenesis/lymphangiogenesis

  2013cited by this paper
• Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned from Animal Models and Human Genetics

  2013cited by this paper
• Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema

  2013cited by this paper
• Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.

  2012cited by this paper
• Crohn's disease

  2012cited by this paper
• Regulation of Adipogenesis by Lymphatic Fluid Stasis: Part I. Adipogenesis, Fibrosis, and Inflammation

  2012cited by this paper
• Ulcerative colitis

  2012cited by this paper
• 9-Cis Retinoic Acid Promotes Lymphangiogenesis and Enhances Lymphatic Vessel Regeneration: Therapeutic Implications of 9-Cis Retinoic Acid for Secondary Lymphedema

  2012cited by this paper
• Integrins and Their Extracellular Matrix Ligands in Lymphangiogenesis and Lymph Node Metastasis

  2012cited by this paper
• Inflammatory bowel disease pathogenesis: what is new?

  2012cited by this paper
• NF‐κB and the link between inflammation and cancer

  2012cited by this paper
• Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease

  2012cited by this paper
• Modelling the lymphatic system: challenges and opportunities

  2012cited by this paper
• Analysis of Nerve Supply Pattern in Human Lymphatic Vessels of Young and Old Men

  2012cited by this paper
• Intestinal mast cells in gut inflammation and motility disturbances.

  2012cited by this paper
• Is lymphatic status related to regression of inflammation in Crohn's disease?

  2012cited by this paper
• Mechanisms of VIP‐induced inhibition of the lymphatic vessel pump

  2012cited by this paper
• Th17-related cytokines in inflammatory bowel diseases: friends or foes?

  2012cited by this paper
• Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

  2012cited by this paper
• [Effects of histamine on contractile activity of lymphatic node capsules. The NO role].

  2011cited by this paper
• Blockade of Transforming Growth Factor-β1 Accelerates Lymphatic Regeneration During Wound Repair

  2011cited by this paper
• Lymphatic anatomy and biomechanics

  2011cited by this paper
• Prostaglandins and Inflammation

  2011cited by this paper
• Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease

  2011influential reference
• D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion.

  2011cited by this paper
• Adipose-derived stem cells promote lymphangiogenesis in response to VEGF-C stimulation or TGF-β1 inhibition.

  2011influential reference
• Heterogeneous expression of toll‐like receptors in lymphatic endothelial cells derived from different tissues

  2011influential reference
• Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.

  2011cited by this paper
• Characterization of Prox1 and VEGFR‐3 Expression and Lymphatic Phenotype in Normal Organs of Mice Lacking p50 Subunit of NF‐κB

  2011cited by this paper
• Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: A review

  2011cited by this paper
• Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: ‘brothers in arms’

  2011cited by this paper
• Cryptotanshinone Inhibits Lymphatic Endothelial Cell Tube Formation by Suppressing VEGFR-3/ERK and Small GTPase Pathways

  2011cited by this paper
• Effects of histamine on contractile activity of lymphatic node capsules. The NO role

  2011cited by this paper
• T lymphocytes negatively regulate lymph node lymphatic vessel formation.

  2011cited by this paper
• Role of the lymphatic system in the pathogenesis of Crohn's disease

  2011influential reference
• Lymphatic pump treatment enhances the lymphatic and immune systems

  2011cited by this paper
• Extraluminal factors contributing to inflammatory bowel disease.

  2011cited by this paper
• Role of transforming growth factor‐&bgr; in inflammatory bowel disease and colitis‐associated colon cancer

  2010cited by this paper
• Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

  2010cited by this paper
• Adaptation of Mesenteric Collecting Lymphatic Pump Function Following Acute Alcohol Intoxication

  2010cited by this paper
• Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.

  2010cited by this paper
• Lymphangiogenesis and lymphatic metastasis in breast cancer.

  2010cited by this paper
• NF-κB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement (Blood (2010) 116, 3, (475-484))

  2010cited by this paper
• Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair.

  2010cited by this paper
• Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation

  2010cited by this paper
• Murine rVEGF164b, an Inhibitory VEGF Reduces VEGF‐A‐Dependent Endothelial Proliferation and Barrier Dysfunction

  2010cited by this paper
• Lymphatic pump manipulation mobilizes inflammatory mediators into lymphatic circulation

  2010cited by this paper
• Lymphatic pump function in the inflamed gut

  2010influential reference
• Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease.

  2010cited by this paper
• Emerging roles of lymphatics in inflammatory bowel disease

  2010influential reference
• Differential susceptibility to epithelial-mesenchymal transition (EMT) of alveolar, bronchial and intestinal epithelial cells in vitro and the effect of angiotensin II receptor inhibition

  2010cited by this paper
• Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF- (cid:1) B and Prox1

  2010influential reference
• Angiopoietin‐2 in experimental colitis

  2010influential reference
• Genes regulated by Nkx2-3 in siRNA-mediated knockdown B cells: implication of endothelin-1 in inflammatory bowel disease.

  2010cited by this paper
• NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement.

  2010cited by this paper
• Regulatory mechanisms in lymphatic vessel contraction under normal and inflammatory conditions.

  2010cited by this paper
• Endothelin axis induces metalloproteinase activation and invasiveness in human lymphatic endothelial cells.

  2010cited by this paper
• The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway

  2010cited by this paper
• Evidence for Activation of the TGF-β1 Promoter by C/EBPβ and Its Modulation by Smads

  2009cited by this paper
• The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

  2009cited by this paper
• Characterization of biosynthesis and modes of action of prostaglandin E2 and prostacyclin in guinea pig mesenteric lymphatic vessels

  2009influential reference
• Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration.

  2009cited by this paper
• Contractile Physiology of Lymphatics

  2009cited by this paper
• Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease

  2009cited by this paper
• The Atypical Chemokine Receptor D6 Contributes to the Development of Experimental Colitis 1

  2009cited by this paper
• Regulation and function of NF-kappaB transcription factors in the immune system.

  2009cited by this paper
• Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis.

  2009cited by this paper
• NF-κB activation in endothelial cells is critical for the activity of angiostatic agents

  2009cited by this paper
• Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels

  2009influential reference
• Lymphatic Endothelial Cells Adapt Their Barrier Function in Response to Changes in Shear Stress

  2009cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Use of sirolimus (rapamycin) to treat refractory Crohn’s disease

  2008cited by this paper
• REGIONAL ILEITISA PATHOLOGIC AND CLINICAL ENTITY

  2008cited by this paper
• Vasoactive Intestinal Peptide as a Healing Mediator in Crohn’s Disease

  2008cited by this paper
• Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.

  2008cited by this paper
• NF‐κB in inflammatory bowel disease

  2008cited by this paper
• Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints

  2008cited by this paper
• The Crohn’s disease susceptibility gene DLG5 as a member of the CARD interaction network

  2008cited by this paper
• Human Lymphatic Endothelial Cells Express Multiple Functional TLRs1

  2008cited by this paper
• Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease

  2008cited by this paper
• NF-κB: a new player in angiostatic therapy

  2008cited by this paper
• Hemopoietic Cell Expression of the Chemokine Decoy Receptor D6 Is Dynamic and Regulated by GATA11

  2008influential reference
• What are the mechanisms of fibrosis in IBD?

  2008cited by this paper
• Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis.

  2008cited by this paper
• Inflammatory bowel disease: cause and immunobiology

  2007cited by this paper
• Lymphangiogenesis in Crohn’s disease: an immunohistochemical study using monoclonal antibody D2-40

  2007cited by this paper
• Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism.

  2007cited by this paper
• Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells*

  2007cited by this paper
• Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor

  2007influential reference
• Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice.

  2007cited by this paper
• Functionally specialized junctions between endothelial cells of lymphatic vessels

  2007cited by this paper

• Reactive Changes in Lymph Node Structure in Peritonitis and during Treatment with a New Antibiotic

  2024cites this paper
• Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells

  2023cites this paper
• Dysregulation of Lymphatic Endothelial VEGFR3 Signaling in Disease

  2023cites this paper
• Changes of L-Arginine Metabolism in Rat`S Colon Mucosa Under the Conditions of COX/LOX Inhibition and Acute Stress Action

  2021cites this paper
• Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease.

  2021cites this paper
• Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn’s disease and control subjects with no inflammatory bowel disease

  2020cites this paper
• Nano-engineered VEGF-C ameliorates gut lymphatic drainage, portal pressure and ascites in experimental portal hypertension

  2020cites this paper
• Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis.

  2019cites this paper
• Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys.

  2019influential citation
• Secondary Lymphedema After Intestinal Tuberculosis: A Case Report

  2019cites this paper
• Efficacy and therapeutic mechanism of mesenchymal stem cell therapy in the management of perianal fistulizing Crohn’s Disease

  2019cites this paper
• Dynamic gut microbiome changes following regional intestinal lymphatic obstruction in primates.

  2019cites this paper
• Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis

  2018cites this paper
• Glucose transporter expression in the human colon

  2018cites this paper
• Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis

  2018cites this paper
• Mesenteric lymph nodes in MR enterography: are they reliable followers of bowel in active Crohn’s disease?

  2018cites this paper
• Mesenteric organ lymphatics and inflammatory bowel disease.

  2018cites this paper
• Obstructive Lymphangitis Precedes Colitis in Murine Norovirus-Infected Stat1-Deficient Mice.

  2018influential citation
• Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn’s disease – review of pathomechanism and existing clinical data

  2018cites this paper
• IL-1β reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 induction: Potential role in myocarditis.

  2018cites this paper
• Vascular Responses to Intestinal Inflammation

  2017cites this paper
• Citrobacter youngae and Pantoea agglomerans Peritonitis in a Peritoneal Dialysis Patient

  2017cites this paper
• Chylous Peritoneal Dialysate Related to the Use of Nutritional Supplements in a Patient with Clostridium difficile Diarrhea

  2017cites this paper
• Anatomy and roles of lymphatics in inflammatory diseases

  2017cites this paper
• A Critical Role for Monocytes/Macrophages During Intestinal Inflammation-associated Lymphangiogenesis

  2016cites this paper
• The Integration of Complementary and Alternative Medicine:The Way Forward for the Health of Skin and Gut

  2016cites this paper
• Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications.

  2016cites this paper
• Lymphangiogenesis in Inflammatory Bowel Disease; A New Therapeutic Target?

  2016cites this paper
• The Gastrointestinal Circulation: Physiology and Pathophysiology.

  2015cites this paper
• Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function?

  2015influential citation
• IL‐1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase‐2 and prostaglandin E2

  2015cites this paper
• Inflammatory bowel disease and lymphology: a discontinuous thread revisited in the molecular era.

  2014cites this paper